Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $0.87 +0.01 (+1.28%) As of 11:28 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Stock Price Performance The Virax Biolabs Group (VRAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 27.42%, with a year-to-date return of -61.29%. In the past month, the stock has decreased 10.99%, reflecting recent market activity. As of the latest close, Virax Biolabs Group traded at $0.86 with a market cap of $3.73 million and volume of 81,542 shares. Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.69%1 Month Performance-10.99%3 Month Performance-0.60%Year-To-Date Performance-61.29%1 Year Performance-27.42% VRAX Stock Chart for Tuesday, July, 8, 2025 VRAX Chart by TradingView Virax Biolabs Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$0.87$0.86-0.58%$0.88$0.8481,542 shs$3.73 million07/04/2025$0.87$0.87$0.87$0.858,750 shs$2.80 million07/03/2025$0.86$0.87+0.59%$0.87$0.858,750 shs$2.79 million07/02/2025$0.83$0.86+3.85%$0.88$0.8311,732 shs$2.78 million07/01/2025$0.79$0.83+4.59%$0.85$0.7730,734 shs$2.67 million06/30/2025$0.78$0.79+1.50%$0.82$0.7491,228 shs$2.56 million06/27/2025$0.77$0.78+1.30%$0.85$0.7539,145 shs$2.52 million06/26/2025$0.76$0.77+1.32%$0.86$0.7627,224 shs$2.49 million06/25/2025$0.80$0.76-5.18%$0.85$0.7537,690 shs$2.46 million06/24/2025$0.76$0.80+5.45%$0.83$0.7836,848 shs$2.59 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$0.80$0.76-5.34%$0.82$0.7522,778 shs$2.46 million06/20/2025$0.81$0.80-0.99%$0.84$0.7631,989 shs$2.60 million06/19/2025$0.81$0.81$0.82$0.8033,452 shs$2.62 million06/18/2025$0.82$0.81-0.98%$0.82$0.8033,452 shs$2.62 million06/17/2025$0.87$0.82-5.89%$0.87$0.8145,760 shs$2.65 million06/16/2025$0.88$0.87-1.38%$0.93$0.8746,228 shs$2.81 million06/13/2025$0.96$0.88-8.07%$0.96$0.8573,967 shs$2.85 million06/12/2025$0.97$0.96-1.52%$1.01$0.9636,583 shs$3.10 million06/11/2025$1.00$0.97-2.52%$1.02$0.9731,768 shs$3.15 million06/10/2025$1.00$1.00-0.10%$1.04$0.9826,796 shs$3.23 million06/09/2025$0.98$1.00+2.30%$1.02$0.9553,529 shs$3.24 million Related Companies Sensei Biotherapeutics Stock Chart X4 Pharmaceuticals Stock Chart Synaptogenix Stock Chart COSCIENS Biopharma Stock Chart PHAXIAM Therapeutics Stock Chart BioCardia Stock Chart NLS Pharmaceutics Stock Chart GlycoMimetics Stock Chart LakeShore Biopharma Stock Chart Addex Therapeutics Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
